Publikationen im NUM

Glatzel M, Hagel C, Matschke J, Sperhake J, Deigendesch N, Tzankov A, Frank S. Neuropathology associated with SARS-CoV-2 infection. Lancet. 2021; 397(10271):276.

Hammerschmidt SI, Bošnjak B, Bernhardt G, et al . Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination. Cell Mol Immunol. 2021; 18(10):      [DOI] 

Stratil JM, Biallas RL, Burns J, Arnold L, Geffert K, Kunzler AM, Monsef I, Stadelmaier J, Wabnitz K, Litwin T, Kreutz C, Boger AH, Lindner S, Verboom B, Voss S, Movsisyan A. Non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent SARS‐CoV‐2 infections and their consequences: a rapid review. Cochrane Database of Systematic Reviews. 2021; 2021CD015085.      [DOI] 

Aguilar C, Silva M, Saraiva M, Neyazi M, Olsson I, Bartfeld S. Organoids as host models for infection biology - a review of methods. Exp Mol Med. 2021; 531471—1482.

Tober-Lau P, Schwarz T, Hillus D, et al . Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerg Infect Dis. 2021; 27(8):      [DOI] 

Tober-Lau P, et al . Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerging infectious diseases. 2021; 27      [DOI] 

Ziegaus , others . Palliativversorgung in Pandemiezeiten im Krankenhaus. Bericht über ein Teilprojekt der "Nationalen Strategie für Palliativversorgung in Pandemiezeiten (PallPan)". KU Gesundheitsmanagement. 2021; (3/2021):

Stiel S, Weber JP, Simon ST, Bausewein C, Schneider N. PallPan: Entwicklung einer „Nationalen Strategie für Palliativversorgung in Pandemiezeiten “. pflegen: Palliativ. 2021; (51):46-48.

Buhr L, Nordmeyer E, Schicktanz S. Pandemie-Apps: Breite Akzeptanz. Dtsch Arztebl International. 2021; 118(27–28):A-1362 / B-1128.

Revet A, Hebebrand J, Anagnostopoulos D, Kehoe L, Child C, Bender S, Klauser P. Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (February/March 2021): ESCAP CovCAP survey. European Child & Adolescent Psychiatry. 2021;      [DOI] 

Weber M, Plew M, Neumann Weber C, et al . Perceived importance of pandemic interventions for attending cultural events – Findings from Germany. BMC Public Health. 2021;      [DOI] 

Kahn M, Schuierer L, Bartenschlager C, et al . Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests. BMC Infect Dis. 2021; 21(1):      [DOI] 

Lee RA, Herigon JC, Benedetti A, et al . Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: A systematic review and meta-analysis. J Clin Microbiol. 2021; 59(5):      [DOI]      [Datei] 

Kreuzberger N, et al . Persistence of immunoglobulin G after natural infection with SARS-CoV-2. Cochrane Database of Systematic Reviews. 2021;      [DOI] 

Michalick L, Weidenfeld S, Grimmer B, Fatykhova D, Solymosi PD, Behrens F, Dohmen M, Brack M, Schulz S, Thomasch E, Simmons S, Müller-Redetzky H, Suttorp N, Kurth F, Neudecker J, Toennies M, Bauer TT, Eggeling S, Corman VM, Hocke AC, Witzenrath M, Hippenstiel S, Kuebler WM. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J. 2021; 57(3):2002384.      [DOI] 

Michalick L, Weidenfeld S, Grimmer B, Fatykhova D, Solymosi P, Behrens F, Dohmen M, Brack M, Schulz S, Thomasch E, others . Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J. 2021; 57(3):      [DOI] 

Joachim A, Dewald F, Suárez I, et al . Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: A cluster randomised trial. EClinicalMedicine. 2021; 39      [DOI] 

Roessler M, Tesch F, Batram M, Jacob J, Loser F, Weidinger O, Wende D, Vivirito A, Toepfner N, Seifert M, Nagel O, König C, Jucknewitz R, Armann JP, Berner R, Treskova-Schwarzbach M, Hertle D, Scholz S, Stern S, Schmitt J, others . Post COVID-19 in children, adolescents, and adults: Results of a matched cohort study including more than 150,000 individuals with COVID-19. 2021;      [DOI] 

Augustin M, et al . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet Regional Health. Europe. 2021; 6100122.      [DOI] 

Niemeyer D, Schroeder S, Friedmann K. Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line. BioRxiv. 2021;      [DOI] 

Niemeyer D, Schroeder S, Friedmann K, Weege F, Trimpert J, Richter ea. Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line. bioRxiv. 2021;      [DOI] 

Niemeyer D, Schroeder S, Friedmann K, Weege F, Trimpert J, Richter A, Stenzel S, Jansen J, Emanuel J, Kazmierski J, Pott F, Jeworowski LM, Olmer R, Jaboreck M, Tenner B, Papies J, Heinze J, Walper F, Schmidt ML, Heinemann N, Möncke-Buchner E, Veith T, Baumgardt M, Hoffmann K, Widera M, Thao TTN, Balázs A, Schulze J, Mache C, Morkel M, Ciesek S, Hanitsch LG, Mall MA, Hocke AC, Thiel V, Osterrieder K, Wolff T, Martin U, Corman VM, Müller MA, Goffinet C, Drosten C. Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line. 2021;      [DOI] 

Heinrich F, Meißner K, Langenwalder F, Püschel K, Nörz D, Hoffmann A, Lütgehetmann M, Aepfelbacher M, Bibiza-Freiwald E, Pfefferle S, Heinemann A. Postmortem stability of SARS-CoV-2 in nasopharyngeal mucosa. Emerg Infect Dis. 2021; 27(1):329-331.      [DOI] 

Boor P, Eichhorn P, Hartmann A, Lax SF, Märkl B, Menter T, Skok K, Slotta-Huspenina J, Stillfried S, Tzankov A, Weirich G. Praktische Aspekte von COVID-19-Obduktionen [Practical aspects of COVID-19 autopsies]. Pathologe. 2021; 42(2):197-207.

Casagrande M, Fitzek A, Spitzer MS, Püschel K, Glatzel M, Krasemann S, Nörz D, Lütgehetmann M, Pfefferle S, Schultheiss M. Presence of SARS-CoV-2 RNA in the cornea of viremic patients with COVID-19. JAMA Ophthalmol. 2021;      [DOI] 

Oestreich M, Chen D, Schultze JL, Fritz M, Becker M. Privacy considerations for sharing genomics data. EXCLI journal. 2021; 201243–1260.      [DOI] 

Weinberger T, Steffen J, Osterman A, et al . Prospective longitudinal serosurvey of healthcare workers in the first wave of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic in a quaternary care hospital in Munich, Germany. Clin Infect Dis. 2021; 73(9):      [DOI] 

Fitzek A, Schädler J, Dietz E, Ron A, Gerling M, Kammal A, Lohner L, Falck C, Möbius D, Goebels H, Gerberding A, Schröder A, Sperhake J, Klein A, Fröb D, Mushumba H, Wilmes S, Anders S, Kniep I, Heinrich F, Langenwalder F, Meißner K, Lange P, Zapf A, Püschel K, Heinemann A, Glatzel M, Matschke J, Aepfelbacher M, Lütgehetmann M, Steurer S, Thorns C, Edler C, Ondruschka B. Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases. Sci Rep. 2021 Sep.; 11(1):19342.      [DOI] 

Lapuente D, Fuchs J, Willar J, et al . Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat Commun. 2021; 12(1):      [DOI]      [Datei] 

Oberste M, Pusch LM, Roth R, et al . Protocol of the Cologne Corona Surveillance (CoCoS) study: A prospective population-based cohort study. BMC Public Health. 2021; 21(1):      [DOI] 

Schwartz J, others . Psychische Belastung des Intensivpersonals: Kommunikationsseminare helfen. Deutsches Ärzteblatt. 2021; 118(50):

Röthke N, Wollschläger D, Kunzler AM, Rohde A, Molter S, Bodenstein M, Reif A, Walter H, Lieb K, Tüscher O. Psychische Belastung, Resilienz und Absentismusneigung bei Gesundheitspersonal in Deutschland während der ersten COVID-19-Pandemiewelle im Frühjahr 2020. Der Nervenarzt. 2021; 92(6):579—590.      [DOI] 

Veer IM, Riepenhausen A, Zerban M, Wackerhagen C, Puhlmann LMC, Engen H, Köber G, Bögemann SA, Weermeijer J, Uściłko A, Mor N, Marciniak MA, Askelund AD, Al-Kamel A, Ayash S, Barsuola G, Bartkute-Norkuniene V, Battaglia S, Bobko Y, others . Psycho-social factors associated with mental resilience in the Corona lockdown. Translational Psychiatry. 2021; 11(1):1—11.      [DOI]      [Datei] 

Morawa E, Schug C, Geiser F, Beschoner P, Jerg-Bretzke L, Albus C, Weidner K, Hiebel N, Borho A, Erim Y. Psychosocial burden and working conditions during the COVID-19 pandemic in Germany: The VOICE survey among 3678 health care workers in hospitals. Journal of Psychosomatic Research. 2021; 144110415.      [DOI] 

Jerg-Bretzke L, Kempf M, Jarczok MN, Weimer K, Hirning C, Gündel H, Erim Y, Morawa E, Geiser F, Hiebel N, Weidner K, Albus C, Beschoner P. Psychosocial Impact of the COVID-19 Pandemic on Healthcare Workers and Initial Areas of Action for Intervention and Prevention—The egePan/VOICE Study. International Journal of Environmental Research and Public Health. 2021; 18(19):10531.      [DOI] 

Bucher A, Kleesiek J, Kuhl CK, Antoch G, others . RACOON: A nationwide radiological infrastructure of German University Radiologies for collaborative imaging research on COVID-19. Conference of the Radiological Society of North America. 2021;

Denzler A, Jacobs ML, Witte V, et al . Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests. MedRxiv. 2021;      [DOI]      [Datei] 

Kluge S, Malin JJ, Fichtner F, Müller OJ, Skoetz N, Karagiannidis C. Recommendations on the In-Hospital Treatment of Patients With COVID-19. Dtsch Arztebl Int. 2021;      [DOI] 

Wagner KI, et al . Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection. Cell reports. 2021; 35110214.      [DOI] 

Bauer S, Contreras S, Dehning J, Linden M, Iftekhar E, Mohr SB, Olivera-Nappa A, Priesemann V. Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves. PLOS Computational Biology. 2021; 17(9):e1009288.      [DOI] 

Thole D, Ole Diesterhöft T, Vogel S, Greve M, Bauer E, Strathmann S, Elsner C, Kolbe N, Krefting D. Relevant Aspects for Sustainable Open Source Pandemic Apps and Platform Deployment with Focus on Community Building. Stud Health Technol Inform. 2021; 283186—193.      [DOI] 

Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf M, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID‐19. Cochrane Database of Systematic Reviews. 2021; 2021(8):CD014962.      [DOI] 

Wurzer D, Spielhagen P, Siegmann A, Gercekcioglu A, Gorgass J, Henze S, Kolar Y, Koneberg F, Kukkonen S, McGowan H, Schmid-Eisinger S, Steger A, Dommasch M, Haase HU, Müller A, Martens E, Haller B, Huster KM, Schmidt G. Remote monitoring of COVID-19 positive high-risk patients in domestic isolation: A feasibility study. PLOS ONE. 2021; 16(9):e0257095.      [DOI]      [Datei] 

Graf S, Engelmann L, Wölfler O, others . Reopening the Bavarian State Opera Safely: Hygiene Strategies and Incidence of COVID-19 in Artistic Staff During Theater Season 2020/2021. Journal of Voice. 2021;      [DOI]      [Datei] 

Salholz-Hillel M, Grabitz P, Pugh-Jones M, Strech D, DeVito NJ. Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study. BMJ Open. 2021; 11(11):e053096.      [DOI] 

Nordsiek F, Bodenschatz E, Bagheri G, et al . Risk assessment for airborne disease transmission by poly-pathogen aerosols. PLOS ONE. 2021;      [DOI] 

Wunsch M, Aschemeier D, Hegera E, et al . Safe and effective pool testing for SARS-CoV-2 detection. J Clin Virol. 2021; 145      [DOI] 

Reis S, Popp M, Schmid B, Stegemann M, Metzendorf M, Kranke P, Meybohm P, Weibel S. Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2021; 11(1):57.      [DOI] 

Hillus D, et al . Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. The Lancet Respiratory Medicine. 2021;      [DOI] 

Möckel M, Corman VM, Stegemann MS, et al . SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarker. 2021; 26(3):      [DOI]